Paul Bujanauskas, MD | |
4940 Eastern Ave, Baltimore, MD 21224-2735 | |
(410) 550-0503 | |
Not Available |
Full Name | Paul Bujanauskas |
---|---|
Gender | Male |
Speciality | Dermatology |
Experience | 34 Years |
Location | 4940 Eastern Ave, Baltimore, Maryland |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1366409534 | NPI | - | NPPES |
376603901 | Medicaid | MD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | D61259 (Maryland) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Kaiser Foundation Health Plan Of The Mid-atlantic States,inc | 3779495858 | 1673 |
Kaiser Foundation Health Plan Of The Mid-atlantic States,inc | 3779495858 | 1673 |
News Archive
A recent video from the Center for Strategic & International Studies (CSIS) on global health and national security discusses the importance of military and non-military health partnerships with middle- and low-income countries, the American Public Health Association's "IH-Blog" reports.
Covidien plc today announced that its Japanese subsidiary, Covidien Japan Inc., has received Shonin approval from the Japanese Ministry of Health, Labor and Welfare for its Endo GIA Reinforced Reload with Tri-Staple technology.
As the aging population continues to grow, the need for qualified geriatric care management standards is increasingly critical. To evolve industry standards and ultimately improve profession-recognized qualifications, the National Association of Professional Geriatric Care Managers (NAPGCM) introduced new membership categories, including the official "Certified Geriatric Care Manager" category which requires specific higher education levels, supervised work experience and one of four industry-sanctioned professional designations.
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that it has initiated a Phase 2, randomized, double-blind, placebo-controlled study evaluating orBec (oral beclomethasone 17,21-dipropionate or BDP) as a treatment for the gastrointestinal manifestations of chronic Graft-versus-Host disease.
› Verified 3 days ago
Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1952461816 PECOS PAC ID: 3779495858 Enrollment ID: O20040105000308 |
News Archive
A recent video from the Center for Strategic & International Studies (CSIS) on global health and national security discusses the importance of military and non-military health partnerships with middle- and low-income countries, the American Public Health Association's "IH-Blog" reports.
Covidien plc today announced that its Japanese subsidiary, Covidien Japan Inc., has received Shonin approval from the Japanese Ministry of Health, Labor and Welfare for its Endo GIA Reinforced Reload with Tri-Staple technology.
As the aging population continues to grow, the need for qualified geriatric care management standards is increasingly critical. To evolve industry standards and ultimately improve profession-recognized qualifications, the National Association of Professional Geriatric Care Managers (NAPGCM) introduced new membership categories, including the official "Certified Geriatric Care Manager" category which requires specific higher education levels, supervised work experience and one of four industry-sanctioned professional designations.
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that it has initiated a Phase 2, randomized, double-blind, placebo-controlled study evaluating orBec (oral beclomethasone 17,21-dipropionate or BDP) as a treatment for the gastrointestinal manifestations of chronic Graft-versus-Host disease.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Paul Bujanauskas, MD Po Box 64252, Baltimore, MD 21264-4252 Ph: () - | Paul Bujanauskas, MD 4940 Eastern Ave, Baltimore, MD 21224-2735 Ph: (410) 550-0503 |
News Archive
A recent video from the Center for Strategic & International Studies (CSIS) on global health and national security discusses the importance of military and non-military health partnerships with middle- and low-income countries, the American Public Health Association's "IH-Blog" reports.
Covidien plc today announced that its Japanese subsidiary, Covidien Japan Inc., has received Shonin approval from the Japanese Ministry of Health, Labor and Welfare for its Endo GIA Reinforced Reload with Tri-Staple technology.
As the aging population continues to grow, the need for qualified geriatric care management standards is increasingly critical. To evolve industry standards and ultimately improve profession-recognized qualifications, the National Association of Professional Geriatric Care Managers (NAPGCM) introduced new membership categories, including the official "Certified Geriatric Care Manager" category which requires specific higher education levels, supervised work experience and one of four industry-sanctioned professional designations.
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that it has initiated a Phase 2, randomized, double-blind, placebo-controlled study evaluating orBec (oral beclomethasone 17,21-dipropionate or BDP) as a treatment for the gastrointestinal manifestations of chronic Graft-versus-Host disease.
› Verified 3 days ago
Sarah Nakib, MD, MPH Dermatology Medicare: Accepting Medicare Assignments Practice Location: 601 N Caroline St, Baltimore, MD 21287 Phone: 410-955-8662 | |
Elizabeth Tanzi, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 600 N Wolfe St, Baltimore, MD 21287 Phone: 410-955-6776 | |
Crystal Ugochi Aguh, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1550 Orleans St, Crb Ii Room 211, Baltimore, MD 21287 Phone: 410-955-2400 Fax: 410-955-8645 | |
Dr. Larry H Gaston, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2300 Garrison Blvd, Suite 260, Baltimore, MD 21216 Phone: 410-945-7544 Fax: 410-945-3605 | |
Dr. Manisha J. Loss, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 601 N Caroline St, Suite 8060b, Baltimore, MD 21287 Phone: 410-502-2082 | |
Dr. Marcia Sanford Driscoll, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 419 W Redwood St, Suite 160, Baltimore, MD 21201 Phone: 410-328-3167 Fax: 410-328-1323 | |
Dr. Myriam Lucia Vega Gonzalez, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 601 N Caroline St # 8072, Baltimore, MD 21287 Phone: 410-955-5933 Fax: 410-502-2309 |